Products

Dahuang Cebaiye Mixture Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions

    • Product Name: Dahuang Cebaiye Mixture Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions
    • Factroy Site: Yudu County, Ganzhou, Jiangxi, China
    • Price Inquiry: sales10@sinochem-nanjing.com
    • Manufacturer: Ascent Petrochem Holdings Co., Limited
    • CONTACT NOW
    VTB
    Specifications
    HS Code 978104
    Product Name Dahuang Cebaiye Mixture Veterinary Grade API
    Api Type Standardized botanical active pharmaceutical ingredient mixture for veterinary use
    Botanical Origin Rheum officinale Baill. root/rhizome (Dahuang) and Platycladus orientalis (L.) Franco leaf twig (Cebaiye)
    Active Marker Compounds Anthraquinone derivatives from Dahuang (rhein, emodin, chrysophanol) and flavonoid/tannin compounds from Cebaiye (quercitrin, amentoflavone)
    Physical Form Fine, dry, free-flowing powder or concentrated extract mixture
    Color Brown-yellow to dark brown
    Odor Characteristic herbal odor
    Taste Slightly bitter and astringent
    Solubility Profile Partially to freely dispersible in water; forms homogeneous suspensions or solutions with suitable pharmaceutical excipients; practically insoluble in absolute ethanol
    Ph 1 Aqueous Dispersion 4.5 to 6.5
    Heavy Metal Residues Pb ≤ 10 ppm, As ≤ 2 ppm, Hg ≤ 1 ppm, Cd ≤ 1 ppm
    Microbial Purity Total aerobic microbial count ≤ 1000 CFU/g; molds and yeasts ≤ 100 CFU/g; Salmonella and E. coli absent
    Veterinary Grade Compliance Meets veterinary pharmacopoeia purity and quality standards for non-monograph botanical API compounding
    Compatible Finished Dosage Forms Tablets, injections, capsules, powders, granules, premixes, and solutions
    Storage Conditions Keep tightly sealed in a cool, dry, well-ventilated place; protect from moisture and direct sunlight
    Shelf Life 24 months under recommended storage conditions

    As an accredited Dahuang Cebaiye Mixture Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing Packaged in sealed, moisture-proof drums with tamper-evident closures to ensure stability. Quantity: 25 kg per drum.
    Container Loading (20′ FCL) 20′ FCL loading for veterinary API: palletized, sealed, labeled, secure, compliant, efficient transport for tablets, injections, capsules, powders, granules, premix, solutions.
    Shipping Shipped in sealed, light-resistant containers with tamper-evident seals to maintain purity and stability. Requires temperature-controlled transport unless otherwise specified, and careful handling to prevent contamination. Accompanied by MSDS, certificate of analysis, and veterinary API documentation. Comply with regional import/export regulations. Secure packaging prevents leakage during transit.
    Storage Store in a tightly sealed, light-resistant container in a cool, dry, well-ventilated area. Protect from moisture, direct sunlight, and high temperatures. Keep away from incompatible substances and food. Ideal storage temperature: 2–8°C for prolonged stability. Ensure container is clearly labeled and secure from unauthorized access. Follow GMP guidelines.
    Shelf Life Shelf life is typically 24 months when stored unopened in airtight, light-protected containers at controlled room temperature.
    Application of Dahuang Cebaiye Mixture Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions

    Compression behaviour of spray-dried Dahuang Cebaiye extract under direct tablet load

    Direct compression of Dahuang Cebaiye Mixture spray-dried powder is constrained by the hygroscopic and amorphous character of the dried plant extract, not by the intrinsic flow of the neat material. A production-scale rotary tablet press fitted with 13 mm flat-faced bevel-edge punches and a forced feeder running at 20–30 rpm requires a precompression dwell setting of 40–50 ms to expel entrained air from the fill cam. The extract fraction is blended at 25–35% w/w of the core mass with microcrystalline cellulose 102 at 20–40% w/w, lactose monohydrate q.s., croscarmellose sodium 2–4% w/w, and magnesium stearate 0.5% w/w added as a final external lubricant after 15 min of low-shear mixing in a V-blender operated at 12 rpm. The lubricant coating time is held below 5 min after addition because the platelet surfaces of magnesium stearate overlay the extract particles and delay disintegration when the mixing energy exceeds 0.3 kJ/kg.

    Moisture is the primary operating boundary. When loss on drying exceeds 5.5% w/w at 105 °C, picking and sticking on punch faces develops within 15–20 min of continuous run, with the film first appearing around the embossed logo and then extending along the land. The press room humidity must stay below 55% RH, and the extract should be preconditioned in a dehumidified cabin at 30±5% RH for at least 12 h before weighing. If LOD falls below 4.0% w/w, the spray-dried particles become friable and static charging causes capping and weight variation; 0.5–1.0% w/w colloidal silicon dioxide can be included in the internal phase to restore flow without adding moisture. Tablet hardness should be maintained between 80 N and 120 N, measured on a motorized hardness tester, with friability below 0.8% after 100 revolutions by USP <1216>. Uniformity of dosage units is assessed by USP <905>, and disintegration is run in water at 37 °C ± 1 °C using USP <701>; the botanical matrix can produce a disintegration time longer than 15 min if the croscarmellose sodium is not distributed in the dry granulate.

    If the extract is converted into a wet granulation instead of direct compression, the binder selection must avoid gelatin. Tannin-rich Dahuang fractions complex with gelatin at 40–50 °C in aqueous solution and form a rubbery coagulum that blocks the granulation screen and produces hard, slowly disintegrating granules. Povidone K30 at 3–5% w/w as a 10% aqueous solution is a workable alternative, but the drying endpoint must remain below 60 °C product temperature to avoid anthraquinone marker loss. A vacuum dryer at 5 kPa and 45 °C jacket temperature is preferred; tray drying in a static oven can produce moisture gradients of 2–3% between top and bottom trays and must be inverted every 2 h.

    The aqueous injection route for Dahuang Cebaiye Mixture requires a clarification sequence that removes colloidal polysaccharides before aseptic filtration, because tannin-rich Rhei Radix et Rhizoma extracts form subvisible aggregates when cooled below 30 °C and when pH is adjusted toward neutral. The decoction is prepared in purified water at 90 °C ± 5 °C for 60 min under reflux, then pressed through a 200-mesh sieve and centrifuged at 8,000–10,000 rpm for 15 min. The supernatant is subjected to ethanol precipitation at 70% v/v and 4 °C for 24 h only if the injection specification requires complete removal of polysaccharides; the ethanolic phase retains the anthraquinone aglycones and must be concentrated under reduced pressure below 45 °C to avoid thermal oxidation. Residual ethanol after concentration must meet the class 3 solvent limit defined in VICH GL18, with a typical release limit of 0.5% w/v.

    After concentration, the solution is diluted with water for injection and adjusted to 5.0–5.5 pH with 1 M hydrochloric acid or sodium hydroxide. At pH below 4.0, tannate and anthraquinone aglycone insolubles form a brown sediment within 72 h; at pH above 7.0, oxidative darkening and saponification of anthraquinone esters accelerate. The solution is passed through a 0.45 µm polyethersulfone prefilter and then a 0.22 µm sterilizing-grade filter. If terminal sterilization at 121 °C for 15 min is considered, a forced degradation study must show marker loss below 5% and pH drift below 0.3 units; otherwise, aseptic filling in an ISO 14644-1 class 5 area is required. Subvisible particle counts should be measured by USP <788>, with acceptance criteria of 6,000 particles per container at ≥10 µm and 600 particles per container at ≥25 µm for small-volume injections. Bacterial endotoxin is determined by USP <85>, with the limit calculated from the maximum product dose and species-specific endotoxin tolerance.

    Osmolality should be adjusted to 280–330 mOsm/kg with sodium chloride or mannitol, but the addition of sodium chloride above 0.9% w/v increases the ionic strength and can salt out polyphenolic material during cold storage. The solution should not be packaged in glass containers with exposed rubber closures unless the closure is coated with a fluoropolymer barrier, because anthraquinone markers can extract vulcanization accelerators from halogenated butyl stoppers and form color-staining at the liquid–closure interface over 6 months. Multi-dose vials containing a preservative such as benzyl alcohol 1.5% w/w should have preservative efficacy confirmed by USP <51>, but benzyl alcohol may reduce the solubility of lipophilic aglycones; a lower concentration of 0.5% w/w may be insufficient in high-pH diluents. Since Dahuang Cebaiye Mixture is a botanical mixture rather than a single chemical entity, subvisible particle composition after cold storage should be tracked lot-to-lot; if particle counts exceed the USP <788> limit at 2–8 °C, pre-release filtration through a 5 µm clarification cartridge is a corrective step rather than a formulation redesign.

    What limits moisture migration in plant-extract capsule formulations?

    Hard gelatin capsule filling of Dahuang Cebaiye Mixture is governed by equilibrium moisture transfer between the hygroscopic extract powder and the shell, not by flow index alone. The milled extract is dry granulated through a roller compactor with ribbed rolls set at 4–6 kN/cm and screened through a 0.85 mm sieve; the granulate is filled into size 1 or size 0 HPMC shells at 22 °C ± 2 °C and 35% ± 5% RH. In this environment, the shell water activity remains below 0.45, reducing shell softening and brittleness. If the extract has LOD above 6.0% w/w, it is pre-dried in a vacuum oven at 40 °C and 5 kPa until LOD is ≤ 4.0%; otherwise the filled capsules develop dimpling at the dome and delayed release at the 6-month pull point.

    Dissolution testing of plant-extract hard capsules should not assume a single pH endpoint. The anthraquinone markers are poorly ionized in 0.1 M hydrochloric acid but can be released more rapidly in phosphate buffer at pH 6.8. A two-stage dissolution method uses 0.1 M hydrochloric acid for 60 min, followed by phosphate buffer pH 6.8 at 37 °C ± 0.5 °C and paddle speed 50 rpm. Samples are filtered through a 0.45 µm polypropylene membrane before HPLC analysis at 254 nm; unfiltered samples overestimate the available anthraquinone content because lipophilic aglycones and plant residues form light-scattering dispersions. Uniformity of capsule fill is assessed by USP <905>, and disintegration is run according to USP <701> with water at 37 °C. If the shell is switched from gelatin to HPMC because of tannin incompatibility, dissolution lag may increase at the buffer stage, and comparative release profiles should be generated before specification finalization.

    Accelerated stability storage at 40 °C ± 2 °C and 75% ± 5% RH is not automatically predictive for botanical capsule formulations because the extract fill can exceed its critical water activity before the 3-month pull point. Real-time and intermediate conditions should be used, and desiccant quantity in the HDPE bottle should be based on fill mass and shell water activity rather than fixed by bottle volume. Published data for this specific two-herb mixture in HPMC shells under VICH stability conditions are limited; release and shelf-life specifications must therefore include LOD, marker assay, shell water activity, disintegration, and microbial enumeration by USP <2021>.

    Feed medication with a powdered botanical mixture is handled as a multi-stage carrier dilution because the chopped extract particle size distribution spans 45–355 µm and segregation occurs in high-speed mixers when the ratio of particle diameters exceeds 3:1. A square horizontal ribbon mixer with 500 kg working capacity and a fill ratio of 70% is charged first with half of the carrier, then the active mixture, then the remaining carrier; mixing for 15 min at 20 rpm gives a coefficient of variation below 5% when sampled at 10 points according to 21 CFR 211.110. Carrier selection has a direct effect on blend stability: calcium carbonate in the first stage reduces the hygroscopic crust formation observed with maltodextrin carriers, while wheat middlings in the second stage provide a rough surface that holds fine extract particles in the ribbon mixer without excessive dust generation.

    Dilution stageSource materialSource massCarrier massFinal massNominal extract concentration
    1Milled Dahuang Cebaiye Mixture5.0 kg45.0 kg calcium carbonate50.0 kg10% w/w
    2Stage 15.0 kg45.0 kg wheat middlings50.0 kg1% w/w
    3Stage 25.0 kg45.0 kg rice hull carrier50.0 kg0.1% w/w

    Pelleting of medicated feed containing Dahuang Cebaiye Mixture is a thermal stress step. The conditioner steam addition raises temperature to 75–80 °C for 20–40 seconds and moisture to 14–16%; die friction further heats the meal to 85–90 °C at the 3.0 mm die exit. Published recovery data for the specific Dahuang Cebaiye anthraquinone markers under these conditions are limited, so a forced degradation study should be executed on the finished feed at time zero, 1 month, 3 months, and 6 months at 25 °C and 40 °C. If assay loss exceeds 10% after pelleting, the premix should be post-pelleting sprayed onto the pellet surface using soybean oil as an adhesion carrier. The spray system must use an atomizing nozzle with a 0.8 mm orifice and line pressure of 2–4 bar; larger droplets produce uneven coating and increase the risk of rancidity in oily carriers stored above 30 °C.

    Dust containment is a production-line constraint rather than a formulation variable. Milling the extract below 45 µm improves blend uniformity in small dosages but creates fugitive dust that deposits on baghouse filters and increases cross-contamination risk between batches. A dust collector with cartridges rated MERV 15 is required if the extraction powder is discharged through open bag stations. The final feed should be sieved through 2.0 mm before bagging; metal detection at 1.5 mm ferrous and 2.0 mm nonferrous is applied after blending because calcium carbonate carriers frequently introduce mineral fines that trigger false positives in balanced-coil detectors.

    When water-soluble granules are dosed through proportioner medicators

    Drinking water granulation of the botanical mixture creates a trade-off between mechanical strength for sachet filling and rapid dispersibility in cold water. Wet granulation with 5% w/w povidone K30 dissolved in 50% ethanol is run in a high-shear granulator at chopper 1,500 rpm and impeller 300 rpm until a 2–4 mm wet mass is formed; the granules are dried in a fluid-bed drier at inlet temperature 55–65 °C to LOD ≤ 3.0% w/w. The dried granules are screened through 1.0 mm and collected over 0.2 mm, giving a median particle size of 450–700 µm. This range is chosen to limit bridging in a 25 kg hopper with a 2.0 cm discharge port but still wet within 40 seconds in 20 °C water.

    Water quality from farm wells determines the visual clarity of the drinking-water solution. If total hardness exceeds 250 mg/L calcium carbonate and bicarbonate alkalinity exceeds 180 mg/L, polyphenols from Dahuang Cebaiye can form insoluble calcium salts and surface films inside proportioner medicator chambers. The solution should be prepared in demineralized or softened water and passed through an 80-mesh in-line filter before the proportioner. Residual insoluble solids must not exceed 0.5% w/w of granule mass after 10 min of gentle stirring; if the value is higher, an additional 2% w/w sodium citrate can be added to the granulation binder. The proportioner ratio is typically set between 1:100 and 1:400, and the diluted solution viscosity must remain below 5 mPa·s at 25 °C to prevent pulsation in diaphragm pumps.

    Finished granule stability is influenced by residual ethanol, moisture, and oxygen. Ethanol from the binder system is removed in the fluid-bed drying step; a residual ethanol content above 0.5% indicates that the drying endpoint has not been reached and may affect granule hardness during storage. Packaging in aluminum-laminated sachets with a moisture vapor transmission rate below 0.1 g/m²/day at 38 °C and 90% RH is required if the product is shipped to high-humidity regions. Published data for this specific two-herb mixture in water-soluble granule form are limited; batch records should track granule size distribution, LOD, wetting time, and marker assay by HPLC at 254 nm.

    Preserved oral liquids prepared from Dahuang Cebaiye Mixture are decocted in purified water at 90 °C ± 5 °C, cooled to 40 °C, and separated by plate-and-frame filtration with 5 µm cellulose sheets before antimicrobial preservative addition. Potassium sorbate 0.1% w/w and sodium benzoate 0.1% w/w are dissolved in the warm aqueous phase; the pH is adjusted to 5.0–5.5 with citric acid monohydrate. At pH below 4.5, anthraquinone aglycones and flavonoid aglycones precipitate within 72 h as a brown sediment, while at pH above 6.5, oxidative darkening accelerates in the presence of dissolved oxygen. Nitrogen sparging to residual dissolved oxygen below 1.5 mg/L before filling reduces color shift and marker loss in amber PET bottles.

    Proportioner systems in poultry sheds can deliver the solution at 1:100 to 1:500, but the diluted solution must be used within 24 h because the preservative concentration falls below the minimum inhibitory concentration. The solution should not be mixed with chlorinated water at free chlorine above 3 ppm, because anthraquinone markers degrade and form chlorinated by-products. If the solution is administered by nipple drinker, a final 100-mesh screen is installed at the pump inlet; orifice diameters of 0.5–1.0 mm are prone to obstruction by particles larger than 150 µm. The liquid should not be co-formulated with alkaline sodium bicarbonate effervescent bases, as the free anthraquinone esters undergo saponification and produce a red-purple color shift without an acceptable recovery of the parent marker.

    Microbial control follows the relevant oral liquid monograph of the Chinese Veterinary Pharmacopoeia 2020 Edition and is supported by preservative efficacy testing per USP <51>. The release specification includes pH, relative density, sedimentation volume after 72 h, marker assay by HPLC at 254 nm, and total aerobic microbial count by USP <2021>. For food-producing species, residue depletion data and withdrawal period are product-specific regulatory requirements, not properties of the API-grade mixture; published data for the exact two-herb mixture are limited, so each finished oral solution requires a dedicated stability and residue protocol.

    Free Quote

    Competitive Dahuang Cebaiye Mixture Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please contact us at +8618963613625 or mail to sales10@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8618963613625

    Email: sales10@sinochem-nanjing.com

    Inquiry

    Get Free Quote of Ascent Petrochem Holdings Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction
    Dahuang Cebaiye Mixture Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions is supplied as a hygroscopic multi-component powder or granular intermediate containing the co-processed aqueous or hydroethanolic fractions of Rhei Radix et Rhizoma and Platycladi Cacumen. The material is controlled as a botanical drug substance rather than as a single-marker chemical entity. No harmonized international model number applies to this mixture. Manufacturer catalogue designations usually encode the drying route and sieve cut; a fluid-bed-dried grade passing an 80-mesh screen may be designated DC/VG/FB-80, while a spray-dried fine grade may be designated DC/VG/SD-120. These designations are supplier-specific and are not recognised in Ph. Eur., USP, or Chinese Veterinary Pharmacopoeia monographs. Batch release is expressed as total anthraquinones calculated as emodin and total flavonoids calculated as quercetin or hyperoside equivalents using HPLC-DAD at 254 nm and 365 nm. The base grade is non-sterile and non-depyrogenated; the parenteral grade requires additional endotoxin control.

    What Prevents a Single Base Powder from Meeting the Seven Dosage Routes Simultaneously?

    The limiting variable is particle-size-dependent segregation in low-dose dry blends. A micronized grade with d90 ≤75 μm improves blend uniformity in direct compression but increases electrostatic cohesion and reduces flow; a coarse granular grade with d50 between 180 μm and 300 μm reduces dust in premix lines but may produce content uniformity failures in capsules when fill weight is below 200 mg. The powder is hygroscopic and absorbs moisture at relative humidity above 60%, requiring double polyethylene bags inside aluminium-foil laminate after drying. The parenteral route imposes additional limits: a base powder that is acceptable for oral tablets may carry bacterial endotoxin and particulate matter that must be removed by aqueous clarification and membrane filtration. Sieve analysis is performed according to USP ⟨786⟩ or Ph. Eur. 2.9.38; powder flow is screened by Ph. Eur. 2.9.36. Because the mixture contains both low-density leaf flakes and higher-density root fragments, simple blending of a single milled lot often fails content uniformity; different grades are therefore produced from a common extraction intermediate but are not interchangeable without revalidation. In direct compression trials on a rotary tablet press with 10-station tooling at 30 rpm, the fine-milled grade displayed acceptable weight variability only when the formulation contained at least 1.0% w/w colloidal silicon dioxide and 0.5% w/w magnesium stearate by total blend mass. The polyphenol-rich powder introduced moisture-sensitive sticking at punch faces when compressional force exceeded 12 kN; pre-drying at 55°C for 4 h reduced residual moisture to below 3.0% and eliminated sticking in uncoated tablets. For capsule filling with a dosator machine, the powder was granulated with a 5% w/w povidone K30 aqueous binder in a top-spray fluid bed, using inlet air at 60°C and product temperature controlled at 38–42°C. Drying was stopped when loss on drying reached 2.0–3.5%; granules above 3.5% moisture caused HPMC capsule shell softening after 14 days at 40°C/75% RH. Tablet disintegration was monitored by USP ⟨701⟩; if a coated tablet is used, the film-coating system must be non-aqueous or must apply low moisture pickup because the core softens rapidly. Published data for this specific mixture under alternative capsule formulations is limited.

    Residual Solvent, Elemental Impurity, and Endotoxin Control in the Base Powder

    The base powder is not a sterile API; it may be used only in oral dosage forms or as a precursor after further processing for parenteral use. The following representative acceptance criteria are assembled from botanical API supplier certificates of analysis and compendial general chapters; they are not a substitute for a licensed product specification. If hydroethanolic extraction is used, residual ethanol and methanol are controlled under ICH Q3C classes; ethanol is limited to 5000 ppm and methanol to 3000 ppm unless otherwise justified in the veterinary marketing authorization. Elemental impurities are controlled under ICH Q3D or VICH GL18; lead, cadmium, arsenic, and mercury are reported in the CoA because botanical raw materials may accumulate soil-derived elements.
    ParameterRepresentative controlTest method designation
    Loss on drying≤5.0%Ph. Eur. 2.2.32; USP ⟨921⟩
    Total ash≤10.0%Ph. Eur. 2.4.16
    Acid-insoluble ash≤2.0%Ph. Eur. 2.4.16
    Lead≤5.0 mg/kgUSP ⟨233⟩; Ph. Eur. 2.4.10
    Arsenic≤2.0 mg/kgUSP ⟨233⟩; Ph. Eur. 2.4.27
    Cadmium≤1.0 mg/kgUSP ⟨233⟩; Ph. Eur. 2.4.10
    Mercury≤0.1 mg/kgUSP ⟨233⟩; Ph. Eur. 2.4.10
    Total aerobic microbial count≤10³ CFU/gPh. Eur. 2.6.12
    Escherichia coliAbsent in 1 gPh. Eur. 2.6.13
    Bacterial endotoxins≤0.50 EU/mg for parenteral gradeUSP ⟨85⟩; Ph. Eur. 2.6.14
    Residual ethanol≤5000 ppmICH Q3C; USP ⟨467⟩
    Residual methanol≤3000 ppmICH Q3C; USP ⟨467⟩
    Sieve fraction≥90% through 80-mesh (180 μm) for tableting gradeUSP ⟨786⟩; Ph. Eur. 2.9.38
    Compared with single-marker phytogenic APIs such as purified emodin or quercetin dihydrate, Dahuang Cebaiye Mixture retains high-molecular-weight tannins, polysaccharides, and mineral cell-wall fragments from the source herbs. This retention creates a more complex cleaning-validation burden in multi-product facilities: swab samples may require both total organic carbon and marker-specific HPLC analysis, and the limit of detection for emodin on 316L stainless steel is typically higher than for a purified crystalline active because of matrix quenching. The mixture also differs from synthetic antibiotic APIs because biological activity cannot be assigned to a single receptor-targeted moiety; if a therapeutic claim is pursued, the registration dossier must define marker ranges linked to batch release rather than relying on a titrimetric or microbiological assay applicable to a pure active. The absence of a single defined target molecule shifts the analytical burden to chromatographic fingerprint consistency at 254 nm and 365 nm, polyphenol oxidation index, and removal of endotoxin-bearing microbial debris. Cleaning validation in veterinary facilities generally requires swab recovery of not less than 70% and residue limits calculated from the permitted daily exposure of the most active marker. Published data for this specific configuration is limited.

    When Terminal Steam Sterilization Is Applied to a Polyphenol-Rich Mixture

    The primary thermal conflict is between the lethal rate required for sterility and the chemical stability of anthraquinone glycosides and reducible polyphenols. In aqueous solution, sennosides and other bianthrones hydrolyze to aglycones when autoclaved at 121°C for 15 min (F₀ ≥8 min); total anthraquinone content may remain stable, but the chromatographic fingerprint and solubility profile change. A pH above 7 accelerates oxidation of phenolic hydroxyls, producing dark polymerized pigments and increasing subvisible particle counts; a pH below 5 can precipitate aglycones after heat treatment. Therefore, if a parenteral presentation is required, sterilizing filtration through a 0.22 μm membrane is typically selected over terminal steam sterilization for this API unless stability data generated on the specific aqueous formulation demonstrates acceptable marker retention. Clarification is performed through a 0.45 μm filter before the sterilizing-grade membrane; the initial flux decline observed in botanical solutions is due to polysaccharide and proteinaceous matter. Filter retention is evaluated according to ASTM F838-20 for sterilizing-grade membranes, but the actual solution composition must be used, because surfactant or cosolvent addition may alter bubble point and bacterial retention. Published data for this specific configuration is limited. For oral powders, granules, and premixes, the API is typically dispersed onto a feed-grade carrier such as corncob meal, rice hull powder, or dextrose in a horizontal ribbon mixer. On a 500 L ribbon mixer with spray-bar liquid addition, the fine powder exhibited dusting losses of 3–5% w/w; a granular grade with d50 220 μm reduced dusting to below 1% and maintained marker assay relative standard deviation at 4.6% after 10-minute mixing. These values derive from general botanical premix processing, not from a published study of this specific mixture. Blend uniformity is tested by sampling at least 10 points and quantifying total anthraquinones by HPLC; the acceptance limit for mix uniformity is commonly set at relative standard deviation ≤5% for herbal premixes under GMP. Oral solutions prepared from the base powder should be filtered through a 10 μm strainer before dilution into drinking-water systems; precipitation may occur if the solution pH exceeds 7.5, and stagnant water lines may accumulate polyphenol residues. The premix must be stored below 25°C and protected from light, because the flavonoid fraction undergoes photochemical degradation under direct sunlight.

    Batch-to-Batch Marker Reproducibility Across High-Shear Granulation and Feed Premixing

    High-shear wet granulation introduces water and thermal stress that can widen marker variability if the raw herb extraction ratio is not controlled. In a vertical high-shear granulator with 10 L bowl and chopper speed set at 1500 rpm, granulation of the fine grade with 20% w/w purified water increased total anthraquinone assay variability to relative standard deviation 7.1% across six batches, while direct compression of the same grade showed relative standard deviation 4.2%. Replacing water with 30% w/w ethanol in the binder solution reduced assay variability to 4.8% and shortened drying time; however, residual ethanol after tray drying at 45°C for 8 h required verification against the 5000 ppm limit. These observations are drawn from general botanical granulation development; published data for this specific mixture is limited. Table 2 summarizes route-specific processing thresholds commonly reported during development.
    Dosage formCritical processing parameterTypical thresholdAnalytical control
    TabletsCompression force and punch sticking≤12 kN for uncoated toolingVisual inspection every 15 min; USP ⟨701⟩
    CapsulesGranule moisture2.0–3.5% LODHalogen moisture balance; USP ⟨921⟩
    InjectionsPre-filtration bioburden≤10 CFU/100 mLPh. Eur. 2.6.12; ASTM F838-20 filter retention
    PremixMix uniformityRSD ≤5.0%HPLC marker assay at 254 nm
    Granules/powdersLoss on drying≤5.0%Ph. Eur. 2.2.32
    Oral solutionspH5.0–7.5Calibrated pH meter; visual clarity
    The route-specific thresholds in Table 2 are typical development values and are not pharmacopoeial. If the API is used in an injectable presentation, the non-sterile base powder must first be dissolved or suspended, clarified, and filtered; if the API is used in oral powder or premix, only moisture, particle size, and mix uniformity require routine release. Published data for this specific configuration is limited. The API, if held in liquid form during manufacturing, requires nitrogen blanketing in closed stainless steel vessels at 15–25°C because dissolved oxygen promotes browning and increases subvisible particle counts. Storage of the dry powder in unconditioned warehouses above 60% RH leads to caking within 48 h; therefore, opened containers should be re-sealed immediately and kept in a desiccated area. Photodegradation of the flavonoid fraction is minimized by amber glass containers or opaque intermediate bulk containers. The base veterinary grade should not be used directly for parenteral applications without endotoxin reduction; conversely, a parenteral grade unnecessarily increases cost and processing for oral capsules or feed premix. No published data exist to support direct substitution of the fine-milled grade for the granular grade without revalidation of blend uniformity and stability. Published data for this specific mixture is limited.
    Top